Augusta, GA, United States of America

Carlos Isales

This inventor holds 2 USPTO granted patents. Top assignee: Augusta University Research Institute, Inc.. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carlos Isales. Retrieved from https://idiyas.com/inventor/carlos-isales

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 50.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Carlos Isales in Inhibiting IDO1

Introduction

Carlos Isales is an accomplished inventor based in Augusta, GA. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that inhibit IDO1. His work focuses on addressing age-related muscle loss and related conditions.

Latest Patents

Carlos Isales holds a patent for "Compositions and methods for inhibiting IDO1." This patent includes compounds that inhibit IDO1 and outlines methods for their use. Additionally, it provides pharmaceutical compositions and medicaments that incorporate these compounds, specifically targeting the treatment of sarcopenia or age-related muscle loss.

Career Highlights

Carlos Isales is affiliated with the Augusta University Research Institute, Inc., where he conducts his research and development work. His innovative approach has led to advancements in understanding and treating muscle degeneration associated with aging.

Collaborations

Carlos collaborates with notable colleagues, including Mark Hamrick and Iryna Lebedyeva, who contribute to his research efforts and enhance the impact of his work.

Conclusion

Carlos Isales exemplifies the spirit of innovation in the pharmaceutical field, with his patent addressing critical health issues related to aging. His contributions are paving the way for new treatments that could significantly improve the quality of life for many individuals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…